The Neonatal Screening Profile type 1 test is an important test performed on newborns during the first days of life. This test aims to screen for a range of genetic and metabolic disorders that could affect the baby’s health and development. The screening involves measuring levels of certain vital substances in the blood, such as hormones and enzymes, which helps in the early detection of conditions like thyroid hormone deficiency, phenylketonuria, and other metabolic disorders. Early detection allows for immediate intervention and appropriate treatment, reducing health risks and improving the chances of healthy growth for the baby. It is recommended that this test be conducted in a hospital or a well-equipped medical center, and the results should be interpreted by a specialist doctor.